Trastuzumab botidotin has met the primary endpoints of its pivotal Phase 2 trial for 3L+ advanced HER2+ BC based on results from the primary analysis, which the Company used to submit an NDA to the ...

The legislation will make it easier for hospitals to make improvements and harder for UMMC to open facilities outside of ...

Officials at ARM, ASGCT, and ISCT convened a small group of scientists, policy experts, religious leaders and patient ...

Tariffs are the centerpiece of a radical plan of U.S. reindustrialization and self-sufficiency - fundamental to MAGA.

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

Here are five ways community colleges have transformed because of the new funding formula: During the COVID-19 pandemic, young Texans cut community college out of their plans. One in ten students in ...

Representatives from Vandalia Health Broaddus Hospital and the Barbour Healthy Communities Collaborative (BHCC ... from health care access and education to economic development and social services.

Here's how Touro School of Health Sciences' 12th annual interprofessional symposium trains future practitioners to improve ...

The new collaboration will drive the development and application of Generative AI solutions ... supply chain optimization, security, and social media management. These solutions leverage advanced ...

New media has profoundly transformed how people interact and form relationships, both online and offline. Social interactions, a fundamental aspect of human ...

Advancement of AbbVie Inc. and OSE Immunotherapeutics strategic partnership to develop ABBV-230: in April 2024, the Hart-Scott-Rodino waiting period expired enabling teams to commence work around the ...